Saccomanno S, Saran S, Coceani Paskay L, De Luca M, Tricerri A, Mafucci Orlandini S, Greco F, Messina G.
Eur J Transl Myol. 2023 Oct 27;33(4):11471. doi: 10.4081/ejtm.2023.11471.
PMID:37905785
Allergic Diseases and Chronic Adenotonsillar Diseases: A Mendelian Randomization Study.
Chen H, Zhu G, Liu Y, Huang D, Zhang X, She L.
Laryngoscope. 2024 Jun;134(6):2653-2658. doi: 10.1002/lary.31275. Epub 2024 Jan 9.
PMID:38193619
Scrophularia buergeriana attenuates allergic inflammation by reducing NF-kappaB activation.
Shin NR, Lee AY, Song JH, Yang S, Park I, Lim JO, Jung TY, Ko JW, Kim JC, Lim KS, Lee MY, Shin IS, Kim JS.
Phytomedicine. 2020 Feb;67:153159. doi: 10.1016/j.phymed.2019.153159. Epub 2019 Dec 24.
PMID:31901567
Investigating the epidemiological relevance of secretory otitis media and neighboring organ diseases through an Internet search.
Guo C, Pan L, Chen L, Xie J, Liang Z, Huang Y, He L.
PeerJ. 2024 Mar 5;12:e16981. doi: 10.7717/peerj.16981. eCollection 2024.
PMID:38464759
Safety and tolerability of fluticasone furoate nasal spray once daily in paediatric patients aged 6-11 years with allergic rhinitis: subanalysis of three randomized, double-blind, placebo-controlled, multicentre studies.
Meltzer EO, Tripathy I, Máspero JF, Wu W, Philpot E.
Clin Drug Investig. 2009;29(2):79-86. doi: 10.2165/0044011-200929020-00002.
PMID:19133703
[Pharyngolaryngeal allergic manifestations].
Andrei V, Bărbulescu E.
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Otorinolaringol. 1980 Jan-Mar;25(1):27-32.
PMID:6446111
Combination therapy with montelukast and loratadine alleviates pharyngolaryngeal symptoms related to seasonal allergic rhinitis.
Imoto Y, Takabayashi T, Sakashita M, Tokunaga T, Morikawa T, Ninomiya T, Okamoto M, Narita N, Fujieda S.
Predictive fiberoptic endoscopic findings of upper airway in children with allergic rhinitis.
Karabulut B, Sahin-Onder S, Erkmen B, Çetemen A, Gergin O.
Int J Pediatr Otorhinolaryngol. 2019 Sep;124:143-146. doi: 10.1016/j.ijporl.2019.06.004. Epub 2019 Jun 5.
PMID:31195307
Direct activation of toll-like receptor 4 signaling in group 2 innate lymphoid cells contributes to inflammatory responses of allergic diseases.
She L, Alanazi HH, Xu Y, Yu Y, Gao Y, Guo S, Xiong Q, Jiang H, Mo K, Wang J, Chupp DP, Zan H, Xu Z, Sun Y, Xiong N, Zhang N, Xie Z, Jiang W, Zhang X, Liu Y, Li XD.
iScience. 2024 Oct 23;27(11):111240. doi: 10.1016/j.isci.2024.111240. eCollection 2024 Nov 15.